Marianne Ellen Pavel

Medizinische Fakultät Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Professur für Endokrinologie

Quality of Life, Tumour Heterogeneity and Biomarker Levels in Patients with Progressive Pancreatic or Midgut Neuroendocrine Tumours: Baseline Data from CLARINET FORTE (2020) Ruszniewski P, Cwikla J, Lombard-Bohas C, Borbath , Shah T, Pape UF, Truong Thanh XM, et al. Conference contribution Prognosis and Management of Advanced Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors (G3 NETs): A NET-CONNECT Study Performed in Four Expert Centers (2020) De Mestier L, Lamarca A, Hernando-Cubero J, Alonso Gordoa T, Cros J, Chakrabarty B, Landolfi S, et al. Conference contribution Palliative CT Brachytherapy in Hepatic Metastatic NET (2020) Feldhaus F, Jann H, Jonczyk M, Boening G, Wieners G, Geisel D, Pavel ME, et al. Conference contribution Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors (2020) Grenader T, Pavel ME, Ruszniewski PB, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, et al. Journal article Serio - Side Effect Registry in Immuno-Oncology (2020) Koutzamanidis R, Mentzer D, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel-Becker S, Pavel ME, et al. Conference contribution Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study (2020) Caplin ME, Pavel ME, Phan AT, Cwikla JB, Sedlackova E, Thanh XMT, Wolin EM, Ruszniewski P Journal article Everolimus-induced pneumonitis in neuroendocrine neoplasms: correlation of CT findings and clinical signs (2020) Fehrenbach U, Rodríguez-Laval V, Jann H, Fernández CM, Pavel ME, Denecke T Journal article Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† (2020) Pavel ME, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A Journal article Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options (2020) Merola E, Prasad V, Pascher A, Pape UF, Arsenic R, Denecke T, Fehrenbach U, et al. Journal article Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 (2020) Merola E, Falconi M, Rinke A, Staettner S, Krendl F, Partelli S, Andreasi V, et al. Journal article